Rochester Drug Cooperative stops opioid distribution amid rising legal fees

Rochester Drug Cooperative will stop distributing opioids amid rising legal and compliance costs, the New York-based drug distribution company said Jan. 14. 

While opioids represent a relatively small percentage of the cooperative's total sales, they account for significant legal and compliance expenses, the distributor said.

"The ever-increasing expenses associated with the legal and regulatory compliance for this segment of drugs are simply not sustainable," the company wrote in a news release.

The company will continue distributing its other products and said it plans to focus more on generic drugs.

Read the full news release here

More articles on pharmacy:
CVS to add 600 HealthHUBs, link them to lower Aetna copays
Civica Rx calls on generic drugmakers to donate to its cause
Pfizer, GlaxoSmithKline give timeline for IPO of joint venture

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months